Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial.

Sacchetti E, Cassano GB, Penati G, Pavan L, Nardini M, Casacchia M, Pancheri P, Muscettola G, Faravelli C, Aguglia E, Nivoli G, Ravizza L, Castrogiovanni P.

Int J Psychiatry Clin Pract. 2002;6(1):23-9. doi: 10.1080/136515002753489380.

PMID:
24931886
2.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
4.

Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.

Pezzella G, Moslinger-Gehmayr R, Contu A.

Breast Cancer Res Treat. 2001 Nov;70(1):1-10.

PMID:
11766999
5.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
6.
9.

Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline.

Hutchinson DR, Tong S, Moon CA, Vince M, Clarke A.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:43-51.

PMID:
1431010
10.
11.

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients.

Geretsegger C, Stuppaeck CH, Mair M, Platz T, Fartacek R, Heim M.

Psychopharmacology (Berl). 1995 Jun;119(3):277-81.

PMID:
7675961
12.

[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.

Encephale. 2009 Dec;35(6):595-604. doi: 10.1016/j.encep.2009.10.011. Epub . French.

PMID:
20004291
13.
14.
15.

Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.

Bauer M, Zaninelli R, Müller-Oerlinghausen B, Meister W.

J Clin Psychopharmacol. 1999 Apr;19(2):164-71.

PMID:
10211918
16.

Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.

Möller HJ, Berzewski H, Eckmann F, Gonzalves N, Kissling W, Knorr W, Ressler P, Rudolf GA, Steinmeyer EM, Magyar I, et al.

Pharmacopsychiatry. 1993 May;26(3):75-8.

PMID:
8415897
17.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
18.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
19.

Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.

Leinonen E, Lepola U, Koponen H, Mehtonen OP, Rimon R.

Acta Psychiatr Scand. 1997 Dec;96(6):497-504.

PMID:
9421348
20.

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.

Eur Psychiatry. 2006 Sep;21(6):367-78. Epub 2006 May 11.

PMID:
16697153
Items per page

Supplemental Content

Write to the Help Desk